Janne Lehtiö, PhD profile page

Professor Janne Lehtiö and the LehtiöLab focus on proteomics and proteogenomics to gain new knowledge on the molecular phenotype of cancer to apply the gained knowledge to improving personalized medicine. Lehtiö received a faculty professor position in medical proteomics at Karolinska Institutet in 2015, and since 2021, has shared a clinical appointment at Karolinska University Hospital as head of the clinical proteomics unit. Since 2008 Lehtiö has been principal investigator at the Department of Oncology and Pathology at Karolinska Institutet, Sweden, currently leading the cancer proteogenomics research group of 40 researchers. Previously, in 2004, Lehtiö was appointed as director of the Karolinska University Hospital’s clinical proteomics facility and since 2010 he has been Scientific Director of Proteomics at SciLifeLab in Stockholm. Since 2024 he has been the project leader of Proteome Medicine Sweden.